Results 121 to 130 of about 89,892 (263)

The impact of COVID-19 on health financing in Kenya. [PDF]

PLOS Glob Public Health, 2023
Kairu A, Orangi S, Mbuthia B, Arwah B, Guleid F, Keru J, Vilcu I, Musuva A, Ravishankar N, Barasa E.   +9 more
europepmc   +2 more sources

Health financing inequality in fragmented health systems: evidence from Mexico, 2000-2023. [PDF]

Int J Equity Health
Serván-Mori E, Cerecero-García D, Pineda-Antúnez C, Jan S, Hone T, Flamand L, Mohar-Betancourt A, Mendoza MÁ, Méndez J, Garcia-Diaz R, Gómez-Dantés O.   +10 more
europepmc   +1 more source

Comparative Evaluation of Hemodiafiltration, Hemoperfusion, and Standard Hemodialysis on Efficacy, Inflammatory Control, Dialysis Adequacy, and Safety in End‐Stage Renal Disease: A Prospective Observational Study

Therapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Background Chronic micro‐inflammation in patients with end‐stage renal disease (ESRD) is a significant driver of cardiovascular complications and diminished quality of life. While standard hemodialysis (SHD) effectively manages small‐molecule clearance, its ability to remove medium‐to‐large uremic toxins—the primary catalysts of systemic ...
Hongwei Zuo, Weisi Dai, Jie Mao, Mei Ye, Xingshan Lu, Xiaocui Zhang   +5 more
wiley   +1 more source

Safety of Daprodustat for the Treatment of Chronic Kidney Disease Anemia: Final Analysis of a Multicenter Postmarketing Surveillance Study in Japan

Therapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Introduction This final analysis of a multicenter, prospective postmarketing surveillance study evaluated the safety of daprodustat in patients with chronic kidney disease anemia in routine clinical practice in Japan. Methods Patients who initiated daprodustat between September 2020 and July 2022 were registered.
Tadao Akizawa, Kyomi Kanaya, Kiyomi Aizawa, Masanori Onoki, Hirofumi Ozeki, Kazuko Suzuki, Ai Hayashi, Tomohiko Asamura   +7 more
wiley   +1 more source

Is health financing converging in the European Union? Nonlinear dynamics and policy implications for non-euro area member states. [PDF]

Front Public Health
Dritsaki M, Dritsaki C, Sarigiannidis P, Genni AG.   +3 more
europepmc   +1 more source

Procedural fairness and the resilience of health financing reforms in Ukraine. [PDF]

Health Policy Plan, 2023
Dzhygyr Y, Dale E, Voorhoeve A, Gopinathan U, Maynzyuk K.   +4 more
europepmc   +1 more source

Forecasting the Dialysis Burden in Japan: Validation‐Based Projections of Prevalence and Incidence Through 2050

Therapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Background Japan has one of the highest dialysis prevalence rates worldwide and a shrinking, aging population. Whether dialysis burden has entered a sustained post‐peak phase or whether recent declines partly reflect pandemic‐related disruptions remains uncertain.
Hatice Şahin, Berrak Itır Aylı, Nüket Paksoy   +2 more
wiley   +1 more source

Health financing policies for aging populations: a comparative study of seven countries. [PDF]

BMC Health Serv Res
Nayebi BA, Yaghoubi R, Najafi B, Khodayari-Zarnaq R.   +3 more
europepmc   +1 more source

Association Between Individualized Education for Kidney Replacement Therapy Modality Selection and Peritoneal Dialysis Initiation: A Cross‐Sectional Study

Therapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Introduction Peritoneal dialysis (PD) is an established home‐based kidney replacement therapy (KRT), but its uptake remains low in Japan. We evaluated whether individualized education in a dedicated outpatient clinic was associated with the initiation of PD.
Yasuko Ito, Ryuichi Yoshimura, Takaki Yamauchi, Yuta Funakoshi, Hirotaka Sonoda, Seiji Kobayashi, Hiroyuki Terawaki, Takafumi Ito   +7 more
wiley   +1 more source

Evaluating Honduras' health financing system: a comprehensive application of the WHO Health Financing Progress Matrix. [PDF]

Rev Panam Salud Publica
Alfaro HE, Forsberg BC.
europepmc   +1 more source